Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant treatment in chronic hepatitis C
2005-002455-41Phase 2Active
- Sponsor
- Karolinska Institutet
- Start
- Dec 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of selenium yeast and coenzyme q10 in hepatitis C virus infection (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Decrease in liver inflammatory activity and Decrease in transaminases. Started Dec 2005; status: active.
02
Drugs
selenium yeastcoenzyme q10
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2005-002455-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002455-41.